Delivery of triptolide with reduction-sensitive polymer nanoparticles for liver cancer therapy on patient-derived xenografts models
Mengxue He(TCM-Intigrated Cancer Center of Southern Medical University), Aimin Li(Washington University in St. Louis), Zhiqiang Yu(Jiangxi Provincial People's Hospital), Ling Yu(The First Affiliated Hospital, Sun Yat-sen University), Wen Ma(Southern Medical University), Meng Yu(Fudan University), Yuanyuan Yang(Southern Medical University), Jiandong Lu(Guangzhou University of Chinese Medicine), Guoliang Xiong(Chinese Academy of Sciences), Binhua Zou(Southern Medical University)
Cited by 97
Related Papers
Neonatal lethality in transgenic mice expressing prion protein with a deletion of residues 105–125
|The EMBO Journal|2007|213
PDGFRβ Cells Rapidly Relay Inflammatory Signal from the Circulatory System to Neurons via Chemokine CCL2
|Neuron|2018|206
Oral Hydrogel Microbeads-Mediated In Situ Synthesis of Selenoproteins for Regulating Intestinal Immunity and Microbiota
|Journal of the American Chemical Society|2023|177
Synergetic delivery of triptolide and Ce6 with light-activatable liposomes for efficient hepatocellular carcinoma therapy
|Acta Pharmaceutica Sinica B|2021|158